SERUM ISCHEMIA-MODIFIED ALBUMIN AS AN OXIDATIVE STRESS BIOMARKER IN LUNG TUBERCULOSIS PATIENT
Ischemia-modified albumin in tuberculosis
DOI:
https://doi.org/10.5281/zenodo.7496483Anahtar Kelimeler:
Tuberculosis, Oxidative stress, ischemia-modified albüminÖzet
Amaç: Bu çalışmanın amacı, tüberküloz hastalarında yeni bir oksidatif stres belirteci olarak iskemi ile modifiye edilmiş albümini (IMA) araştırmaktı. Gereç ve yöntem: Çalışmamıza aktif akciğer tüberkülozu olan 49 hasta ve 45 sağlıklı kontrol dahil edildi. Serum IMA otomatik spektrometrik yöntemle ölçüldü ve sonuçlar istatistiksel olarak karşılaştırıldı. Bulgular: Akciğer tüberkülozu hastalarında IMA düzeylerinin kontrol grubuna göre anlamlı derecede yüksek olduğunu bulduk. Albümin seviyeleri hasta grubunda kontrol grubuna göre anlamlı derecede düşüktü. Sonuç: Çalışma, bu parametreyi pulmoner tüberküloz patogenezinde yeni bir oksidatif stres belirteci olarak kullanabileceğimizi göstermiştir.
Referanslar
World Health Organization. Global tuberculosis report 2019. Geneva, Switzerland: World Health Organization; 2019. https://www.who. int/tb/publi catio ns/global_repor t/en/
World Health Organization. Global tuberculosis report 2017. www. who.int/tb/publi catio ns/global_repor t/en/
Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982; 47 (5): 412-26
Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991; 91(3C): 14-22
Chong WC, Shastri MD and Eri R. Endoplasmic reticulum stress and oxidative stress: a vicious nexus implicated in bowel disease pathophysiology. International Journal of Molecular Sciences. 2017; 18 (4): 771
Gundamaraju R, Vemuri R, Chong WC et al. Cell stress signaling cascades regulating cell fate. Curr Pharm Des 2018; 24 (27): 3176-3183. Doi: 10.2174/1381612824666180711122753
Cheresh P, Kim SJ, Tulasiram S et al. Oxidative stress and pulmonary fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2013: 1832 (7): 1028–40
Marino E, Caruso M, Campagna D et al. Impact of air quality on lung health: myth or reality?. Therapeutic Advances in Chronic Disease. 2015; 6 (5): 286–98
Holguin F. Oxidative stress in airway diseases. Annals of the American Thoracic Society. 2013; 10: 150–7
Ingbar DH. Fishman’s pulmonary diseases and disorders. Annals of the American Thoracic Society. 2015; 12 (8): 1255-6
Nambi S, Long JE, Mishra BB et al. The oxidative stress network of Mycobacterium tuberculosis reveals coordination between radical detoxification systems. Cell Host & Microbe. 2015; 17 (6): 829–37
Oberley-Deegan RE, Rebits BW, Weaver MR, T et al. An oxidative environment promotes growth of Mycobacterium abscessus. Free Radical Biology and Medicine. 2010; 49 (11): 1666-73
Goyal N, Kashyap B, Singh N et al. Neopterin and oxidative stress markers in the diagnosis of extrapulmonary tuberculosis. Biomarkers. 2017; 22 (7): 648–53
Santus P, Corsico A, Solidoro P et al. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine. J Chron Obstruct Pulmon Dis. 2014; 11 (6): 705-17
Taverna M, Marie AL, Mira JP et al. Specific antioxidant properties of human serum albumin. Ann Intensive Care 2013; 3: 4
Bar-Or D, Curtis G, Rao N et al. Characterization of the Co (2+) and Ni (2+) binding amino acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268: 42-7
Apple FS. Clinical and analytical review of ischemia-modified albumin measured by the albumin cobalt binding test. Adv Clin Chem. 2005; 39: 1-10
Bar-Or D, Lau E,Winckler JV. A novel assay for cobalt-albumin binding and its potential as amarker ofmyocardial ischemia—a preliminary report. J EmergMed 2000; 19: 311–5
Lippi G, Montagnana M. Ischemia modified albumin in ischemic disorders. Ann Thorac Cardiovasc Surg 2009; 15: 137
Dundar ZD, Cander B, Gul M et al. Serum ischemia-modified albumin levels in an experimental acute mesenteric ischemia model. Acad Emerg Med. 2010; 17 (11): 1233-8
World Health Organization. Global tuberculosis report 2018 (Report No.: ISBN 978-92-4 156564-6).Geneva: WHO. 2018.http://www.who.int/tb/publi catio ns/global_repor t/en/
De Oliveira HG, Rossatto ER, Prolla JC. Pleural fluid adenosine deaminase and lymphocyte proportion: clinical usefulness in the diagnosis of tuberculosis, Cytopathology. 1994; 5 (1): 27-32
Kwiatkowska S, Piasecka G, Zieba M et al. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis, Respiratory medicine. 1999; 93 (4): 272-6
Amaral EP, Conceicao EL, Costa DL et al. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. BMC Microbiol. 2016; 16: 251
Demir E, Giden R, Sak Zafer HA et al. Thiol‐disulphide homoeostasis as a novel oxidative stress biomarker in lung tuberculosis patient. Int J Clin Practice . 05 January 2021;e13998. https://doi.org/10.1111/ijcp.13998
Durak I, Canbolat O, Kavutçu M et al. Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer, Journal of clinical laboratory analysisç. 1996; 10 (1): 17-20
Güney Y, Bilgihan A, Çiftçi TU et al. Serum Malondialdehyde Levels and Superoxide Dismutase Activities in Pulmonary Tuberculosis and Lung Cancers. Meslek Yuksekokulu Dergisi. 2004; 6: 33-8.
Reddy Y, Murthy SV, Krishna DR et al. Role of free radicals and antioxidants in tuberculosis patients. Indian J Tubercu. 2004; 51: 213-8
Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free RadicBiol Med 2013; 65: 244-53
Kaefer M, Piva SJ, De Carvalho JAM et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010; 43: 450–4
Can U, Yerlikaya FH, Yosunkaya S. Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease. J Chin Med Assoc. 2015; 78 (12): 702-8
Kaplan M, Yuksel M, Ates I et al. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases? J Gastroen Hepatol. 2016; 31 (6): 1120-5
Turedi S, Gunduz A, Mentese A et al. The value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med. 2007; 25: 770-3
D'souza JM, Pai VR, Harish S et al. IMA and IMAR in serum andsaliva of preeclampsia a preliminary study. Hypertens Pregnancy 2014; 33: 440- 8
Bolatkale M, Duger M, Ülfer G et al. A novel biochemical marker for community-acquired pneumonia: ischemia-modified albumin. Am J Emerg Med. 2017; 35: 1121–5
İndir
Yayınlanmış
Nasıl Atıf Yapılır
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2022 EJONS INTERNATIONAL JOURNAL
Bu çalışma Creative Commons Attribution-NonCommercial 4.0 International License ile lisanslanmıştır.
